Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Moreno

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Cadernos De Saude Publica|February 12, 2025
Association between trust in the incumbent president and COVID-19 preventive behaviors during the pandemic in four Latin American countriesJuliana Mejía-Grueso, Gloria Isabel Niño-Cruz, Javiera Alarcón-Aguilar, et al.
Health Science Reports|June 14, 2024
Severity and mortality of acute respiratory failure in pediatrics: A prospective multicenter cohort in Bogotá, ColombiaCatalina Vargas-Acevedo, Mónica Botero Marín, Catalina Jaime Trujillo, et al.
Frontiers in Global Women'S Health|February 23, 2023
COVID-19 in children and the influence on the employment activity of their female caregivers: A cross sectional gender perspective studyCatalina Jaime Trujillo, Natalia Herrera Olano, Kevin Rico Gutiérrez, et al.
Oncotarget|June 6, 2026
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrenceEmily Bivens, Omar Atiq, Teresa Evans, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer RecurrenceEmily Bivens, Omar Atiq, Teresa Evans, et al.
Journal of Clinical Epidemiology|June 17, 2026
Patient-Important Outcomes Reported as Primary Outcomes in Clinical Studies of Treatments for COVID-19: A Meta-Epidemiological StudyJulia Bidonde, Laura Yuriko González-Teshima, Sergio Mauricio Moreno Lopez, et al.
G3 (Bethesda, Md.)|February 17, 2024
Chromosome-level assembly of the gray fox (Urocyon cinereoargenteus) confirms the basal loss of PRDM9 in CanidaeEllie E Armstrong, Ky L Bissell, H Sophia Fatima, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Cadernos De Saude Publica|February 12, 2025
Association between trust in the incumbent president and COVID-19 preventive behaviors during the pandemic in four Latin American countriesJuliana Mejía-Grueso, Gloria Isabel Niño-Cruz, Javiera Alarcón-Aguilar, et al.
Health Science Reports|June 14, 2024
Severity and mortality of acute respiratory failure in pediatrics: A prospective multicenter cohort in Bogotá, ColombiaCatalina Vargas-Acevedo, Mónica Botero Marín, Catalina Jaime Trujillo, et al.
Frontiers in Global Women'S Health|February 23, 2023
COVID-19 in children and the influence on the employment activity of their female caregivers: A cross sectional gender perspective studyCatalina Jaime Trujillo, Natalia Herrera Olano, Kevin Rico Gutiérrez, et al.
Oncotarget|June 6, 2026
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrenceEmily Bivens, Omar Atiq, Teresa Evans, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer RecurrenceEmily Bivens, Omar Atiq, Teresa Evans, et al.
Journal of Clinical Epidemiology|June 17, 2026
Patient-Important Outcomes Reported as Primary Outcomes in Clinical Studies of Treatments for COVID-19: A Meta-Epidemiological StudyJulia Bidonde, Laura Yuriko González-Teshima, Sergio Mauricio Moreno Lopez, et al.
G3 (Bethesda, Md.)|February 17, 2024
Chromosome-level assembly of the gray fox (Urocyon cinereoargenteus) confirms the basal loss of PRDM9 in CanidaeEllie E Armstrong, Ky L Bissell, H Sophia Fatima, et al.
Pageof 8